Table IV.
Univariable analysis | Multivariable analysis | |||
---|---|---|---|---|
|
|
|||
Parameters | P-value | HR (95 CI) | P-value | HR (95 CI) |
Gender | ||||
Female vs. male | 0.069 | 2.38 (0.93–6.11) | ||
Age (years) | ||||
>62 vs.≤62 | 0.42 | 0.69 (0.27–1.71) | ||
Tumor size (cm) | ||||
>7 vs.≤7 | 0.46 | 0.71 (0.29–1.75) | ||
Tumor grade | ||||
T3+4 vs. T1+2 | 0.0001 | 8.37 (2.76–25.35) | 0.28 | 1.95 (0.57–6.64) |
Histological grade | ||||
F3+4 vs. F1+2 | <0.0001 | 34.08 (4.50–258.08) | 0.007 | 18.28 (2.19–152.39) |
RASSF1A mRNA levels | ||||
(≤0.266) vs. (>0.266) | 0.004 | 6.06 (1.76–20.91) | 0.02 | 2.25 (0.62–8.12) |
RASSF1A methylation | ||||
(>25) vs. (≤25%) | 0.02 | 3.00 (1.18–7.65) | 0.22 | 1.88 (0.68–5.18) |
RASSF1A protein levels | ||||
(≤10.09) vs. (>10.09) | 0.32 | 0.54 (0.15–1.85) | ||
RASSF1C mRNA levels | ||||
(>0.191) vs. (≤0.191) | 0.83 | 0.91 (0.34–2.37) | ||
RASSF1C protein levels | ||||
(>3.03) vs. (≤0.191) | 0.35 | 2.01 (0.46–8.72) |